ANNA BAHÍ SALAVEDRA

Malalties Digestives i Microbiota
Firma
ANNA BAHÍ-SALAVEDRA
Posició
Investigador/a postdoctoral

Projectes

Codi oficial: RTC-2017-6467-2 Data inici: 18/09/2018 Data fi: 30/09/2021 Investigador/a principal: XAVIER ALDEGUER MANTE Organisme finançador: MINISTERIO DE ECONOMIA Y COMPETITIVIDAD Ajuda: 182,055 €
Codi oficial: La Marató 201912-31 Data inici: 30/09/2020 Data fi: 30/09/2023 Investigador/a principal: XAVIER ALDEGUER MANTE Organisme finançador: FUNDACIO LA MARATO TV3 Ajuda: 199,812.50 €

Publicacions

Malagón M, Ramió-Pujol S, Serrano M, Amoedo J, Oliver L, Bahí A, Miquel-Cusachs JO, Ramirez M, Queralt-Moles X, Gilabert P, Saló J, Guardiola J, Piñol V, Serra-Pagès M, Castells A, Aldeguer X, Garcia-Gil LJ

New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population.

Plos One, 2020, 15, e0243158 dx.doi.org/10.1371/journal.pone.0243158

Malagón M, Ramió-Pujol S, Serrano M, Serra-Pagès M, Amoedo J, Oliver L, Bahí A, Mas-de-Xaxars T, Torrealba L, Gilabert P, Miquel-Cusachs JO, García-Nimo L, Saló J, Guardiola J, Piñol V, Cubiella J, Castells A, Aldeguer X, Garcia-Gil J

Reduction of faecal immunochemical test false-positive results using a signature based on faecal bacterial markers.

ALIMENT PHARM THERAP, 2019, 49, 1410-1420 dx.doi.org/10.1111/apt.15251

Busquets D, Mas-de-Xaxars T, López-Siles M, Martínez-Medina M, Bahí A, Sàbat M, Louvriex R, Miquel-Cusachs JO, Garcia-Gil JL, Aldeguer X

Anti-tumour Necrosis Factor Treatment with Adalimumab Induces Changes in the Microbiota of Crohn's Disease.

JOURNAL OF CROHNS & COLITIS, 2015, 9, 899-906 dx.doi.org/10.1093/ecco-jcc/jjv119

Formulari de contacte

menu